We are live on ! Find out more
PCA

Providence Capital Advisors Portfolio holdings

AUM $613M
1-Year Est. Return 17.83%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+17.83%
3 Year Est. Return
+42.1%
5 Year Est. Return
+50.05%
10 Year Est. Return
AUM
$321M
AUM Growth
+$11.5M
Cap. Flow
+$16.1M
Cap. Flow %
5.01%
Top 10 Hldgs %
26.2%
Holding
358
New
36
Increased
93
Reduced
39
Closed
39

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$4.11M
2
GLW icon
Corning
GLW
+$4.02M
3
BAX icon
Baxter International
BAX
+$3.78M
4
BSX icon
Boston Scientific
BSX
+$3.65M
5
CSX icon
CSX Corp
CSX
+$3.5M

Sector Composition

Rank Sector Weight
1 Technology 22.33%
2 Healthcare 13.54%
3 Financials 12.68%
4 Communication Services 10.01%
5 Consumer Staples 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$14.2M 4.43%
100,384
+2,932
+3% +$432K
IVV icon
2
iShares Core S&P 500 ETF
IVV
$876B
$10.1M 3.14%
23,390
+73
+0.3% +$32.3K
MSFT icon
3
Microsoft
MSFT
$2.84T
$9.46M 2.95%
33,555
-12,871
-28% -$3.74M
JPM icon
4
JPMorgan Chase
JPM
$939B
$9.17M 2.86%
56,030
+2,097
+4% +$329K
DIS icon
5
Walt Disney
DIS
$165B
$8.12M 2.53%
48,016
+2,792
+6% +$498K
GOOG icon
6
Alphabet (Google) Class C
GOOG
$3.9T
$7.65M 2.38%
57,400
+2,920
+5% +$403K
PFE icon
7
Pfizer
PFE
$140B
$6.82M 2.13%
158,665
+9,987
+7% +$442K
BAC icon
8
Bank of America
BAC
$435B
$6.29M 1.96%
148,160
+6,832
+5% +$275K
IBM icon
9
IBM
IBM
$202B
$6.19M 1.93%
46,600
+4,983
+12% +$666K
MRK icon
10
Merck
MRK
$324B
$6.07M 1.89%
80,819
+8,704
+12% +$662K
ZBRA icon
11
Zebra Technologies
ZBRA
$12.4B
$6M 1.87%
11,644
+600
+5% +$334K
NXPI icon
12
NXP Semiconductors
NXPI
$68B
$5.75M 1.79%
29,367
+1,389
+5% +$288K
VZ icon
13
Verizon
VZ
$194B
$5.75M 1.79%
106,452
+6,149
+6% +$340K
ETN icon
14
Eaton
ETN
$157B
$5.54M 1.73%
37,098
+1,796
+5% +$287K
HD icon
15
Home Depot
HD
$332B
$5.44M 1.7%
16,570
+787
+5% +$258K
TMO icon
16
Thermo Fisher Scientific
TMO
$211B
$5.37M 1.67%
9,396
+489
+5% +$268K
ABT icon
17
Abbott
ABT
$180B
$5.1M 1.59%
43,187
+1,731
+4% +$213K
IEFA icon
18
iShares Core MSCI EAFE ETF
IEFA
$186B
$5.09M 1.59%
68,589
+3,747
+6% +$285K
BN icon
19
Brookfield
BN
$102B
$4.97M 1.55%
172,244
+8,353
+5% +$244K
BLK icon
20
Blackrock
BLK
$164B
$4.69M 1.46%
5,596
+276
+5% +$247K
CMCSA icon
21
Comcast
CMCSA
$79.1B
$4.53M 1.41%
80,954
+3,966
+5% +$231K
FFIV icon
22
F5
FFIV
$22.1B
$4.5M 1.4%
22,640
+1,127
+5% +$225K
TGT icon
23
Target
TGT
$62.1B
$4.47M 1.39%
19,550
-5,129
-21% -$1.28M
CMCO icon
24
Columbus McKinnon
CMCO
$465M
$4.47M 1.39%
92,376
+29,939
+48% +$1.36M
STZ icon
25
Constellation Brands
STZ
$22.2B
$4.27M 1.33%
20,274
+649
+3% +$142K

Similar funds

Providence Capital Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Providence Capital Advisors held 358 positions worth $321M, up 3.7% from $309M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Providence Capital Advisors deployed $16.1M of net new capital in Q3 2021, opening 36 new positions and adding to 93 existing holdings. Its largest new stake was Boston Scientific: 82,600 shares worth $3.58M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $4.44M trimmed.

  • Providence Capital Advisors's largest Q3 2021 buy was Boston Scientific: 82,600 shares worth $3.58M.
  • Providence Capital Advisors added most to Starbucks in Q3 2021, an estimated $4.11M increase.
  • Providence Capital Advisors's biggest Q3 2021 reduction was Gilead Sciences, cutting an estimated $4.44M.
  • Providence Capital Advisors fully exited Johnson Controls International in Q3 2021, selling an estimated $3.69M.
  • Providence Capital Advisors's ten largest holdings make up 26% of its $321M portfolio in Q3 2021.
  • Providence Capital Advisors opened 36 new positions and closed 39 in Q3 2021.
  • Providence Capital Advisors's portfolio value rose 3.7% quarter-over-quarter to $321M.

Based on Providence Capital Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.